【和黄医药早盘高开逾 3%，截至发稿股价上涨 7.10%，现报 24.15 港元，成交额 1.38 亿港元。】 和黄医药发布公告，沃瑞沙?和泰瑞沙?（TAGRISSO?，奥希替尼/osimertinib）的联合疗法用于治疗伴有 MET 扩增的接受一线表皮生长因子受体抑制剂治疗后疾病进展的 EGFR 突变阳性局部晚期或转移性非小细胞肺癌患者的新药上市申请已获中国国家药品监督管理局受理并予以优先审评。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.